ABS Capital Partners
AIG Capital Partners - VS
Altamira
Axiom Venture Partners- VS
Baker/Tisch
Biotech Value Fund
Capital Research Management - VS
Care Capital - VS
Chatterjee Group
China Development Industrial Bank of Taiwan
CIT Ventures - life sciences - technology
Deutsche Venture Capital - VS
Emerging Growth Management
EndPoint Late-Stage Fund
Frankel Group / Equity4Life
Galleon Group
Genechem
Hambrecht & Quist Capital - VS
Hancock Mezzanine Investments
Investor Growth Capital - VS
International Biotechnology Trust plc of London (VS)
KBC Asset Management
Lehman Brothers Venture Partners - VS
Lombard Odier
MDS Capital (Toronto) (VS)
Mehta Partners
Meisenbach Capital
Morgan Stanley Venture Partners
MVM Limited - VS
NeoMed Fund (Norway)
NMT Asset Management - VS
Oakwood Medical Investors - VS
Odin Partners
Ontario Teachers' Pension Plan
OrbiMed Advisors - VS
Palladin Group
Perseus-Soros Biopharmaceutical Fund
Pogue Capital
Putnam Investment Managememt
Sanderling BioMedical Ventures (VS)
Schroder Ventures - VS
Singapore BioInnovations (Singapore) (VS)
Singapore Economic Development Board
Sofinov - VS
Sprout Group - VS
Temasek Capital (Singapore)
Three Arch Partners - VS
Thomas Weisel Partners - VS
United Capital
U.S. Trust Private Equity - VS
Ventures West
Walden International - VS
Warburg Pincus - VS
|